A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer
Clinical trial NCT04181372 · UNKNOWN
Trial details
- NCT number
- NCT04181372
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2021-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.